Cite
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
MLA
Sunil Krishnan, et al. Immunotherapy and Stereotactic Ablative Radiotherapy (ISABR): A Curative Approach? Mar. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e55595b277e06454c92593e54de6ffb7&authtype=sso&custid=ns315887.
APA
Sunil Krishnan, Michael B. Bernstein, Joe Y. Chang, & James W. Hodge. (2016). Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Chicago
Sunil Krishnan, Michael B. Bernstein, Joe Y. Chang, and James W. Hodge. 2016. “Immunotherapy and Stereotactic Ablative Radiotherapy (ISABR): A Curative Approach?,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e55595b277e06454c92593e54de6ffb7&authtype=sso&custid=ns315887.